RIMSO-50
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- RIMSO-50
- Generic name
- DIMETHYL SULFOXIDE
- Manufacturer
- Mylan Institutional LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 58b25d79-78f2-4953-b0c6-61658dc4ef0d
- SPL ID
- ed5bd01d-2175-457e-ae65-7197f40d7342
- Version
- 9
- Effective date
- 2021-03-17
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:53:18
| Harmonized routes |
|---|
| INTRAVESICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 017788 | derived:openfda.application_number |
| application number | NDA017788 | openfda.application_number | |
| brand name | RIMSO-50 | openfda.brand_name | |
| generic name | DIMETHYL SULFOXIDE | openfda.generic_name | |
| manufacturer name | Mylan Institutional LLC | openfda.manufacturer_name | |
| ndc | package | 67457-177-50 | openfda.package_ndc |
| ndc | product | 67457-177 | openfda.product_ndc |
| ndc11 | package | 67457017750 | derived:openfda.package_ndc |
| rxcui | 208361 | openfda.rxcui | |
| rxcui | 562359 | openfda.rxcui | |
| spl id | ed5bd01d-2175-457e-ae65-7197f40d7342 | id | |
| spl set id | 58b25d79-78f2-4953-b0c6-61658dc4ef0d | set_id | |
| unii | YOW8V9698H | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Dimethyl sulfoxide can initiate the liberation of histamine and there has been occasional hypersensitivity reaction with topical administration of dimethyl sulfoxide. This hypersensitivity has been reported in one patients receiving intravesical RIMSO-50 ® . The physician should be cognizant of this possibility in prescribing RIMSO-50 ® . If anaphylactoid symptoms develop, appropriate therapy should be instituted.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS A garlic-like taste may be noted by the patient within a few minutes after instillation of RIMSO-50 ® (dimethyl sulfoxide). This taste may last several hours and because of the presence of metabolites, an odor on the breath and skin may remain for 72 hours. Transient chemical cystitis has been noted following instillation of dimethyl sulfoxide. The patient may experience moderately severe discomfort on administration. Usually this becomes less prominent with repeated administration.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.